0
ARTICLE |

Estrogen and Progesterone Receptors in Head and Neck Cancer FREE

David E. Schuller, MD; Hussein Abou-Issa, PhD; Robert Parrish, MD
[+] Author Affiliations

Accepted for publication June 18, 1984.

Read before the American Society for Head and Neck Surgery, Palm Beach, Fla, May 10, 1984.

Reprint requests to Department of Otolaryngology, Ohio State University, 456 Clinic Dr, Columbus, OH 43210 (Dr Schuller).


Arch Otolaryngol Head Neck Surg. 1984;110(11):725-727. doi:10.1001/archotol.1984.00800370027006
Text Size: A A A
Published online

• The existence of hormone receptors on or within neoplastic tissue has potential diagnostic, therapeutic, and prognostic importance. It was the purpose of this study to measure estrogen and progesterone receptors in a large group of patients with head and neck cancer to determine their frequency. Sixty-five patients with head and neck tumors underwent a total of 75 estrogen and 50 progesterone receptor assays. In this group, 87.7% were squamous cell carcinoma. In the estrogen receptor assays, 89.3% (67/75) were negative, 8% (6/75) were borderline, and only 2.7% (2/75) were positive. In the progesterone receptor assays, 78% (39/50) were negative, 22% (11/50) were borderline, and there were no positive results. There were no changes in assays of tissue removed at biopsy v tissue removed during surgery. There was no impact with chemotherapy. In conclusion, head and neck cancers do not appear to possess estrogen or progesterone receptors and can be considered to be hormonally independent.

(Arch Otolaryngol 1984;110:725-727)

REFERENCES

Molten A, Warpeha R, Brizio-Molteni L, et al:  Estradiol receptor-binding protein in head and neck neoplastic and normal tissue . Arch Surg 1981;;116:207-210.
Scatchard G:  The attractions of proteins for small molecules and ions . Ann NY Acad Sci 1949;;51:660-672.
Lowry OH, Rosebrough NJ, Farr AL, et al:  Protein measurement with the folinphenol reagent . J Biol Chem 1951;;193:265-275.
Jensen EV, deSombre R:  The diagnostic implications of steriod binding in malignant tissues . Adv Clin Chem 1977;;19:57-59.
McCarthy KS Jr, McCarthy KS Sr:  Steriod hormone receptors in the regulations of differentiation . Am J Pathol 1977;;86:704-744.
McGuire WL, Horwitz KB, Zava DT, et al:  Hormones in breast cancer: Update 1978 . Metabolism 1978;;27:487-501.
Parl FF, Wagner RK:  The histopathological evaluation of human breast cancer in correlation with estrogen receptor values . Cancer 1980;; 46:362-367.
Stedman KE, Moore GE, Morgan RT:  Estrogen receptor proteins in diverse human tumors . Arch Surg 1980;;115:244-248.
McCarty KS Jr, Barton TK, Fetter BF, et al:  Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma . Cancer 1980;;46:2851-2858.
Concoline G, Marocchi A, Contil C, et al:  Human renal cell carcinoma as a hormone dependent tumor . Cancer Res 1978;;38:4340.
McClendon J, Appleby D, Clandon D, et al:  Colonic neoplasms: Tissue estrogen receptors and carcinoembryonic antigens . Arch Surg 1977;;112:240-241.
Fischer RI, Neifeld JP, Lipmann ME:  Oestrogen receptors in human malignant melanoma . Lancet 1976;;2:337-338.
Gustaffson J, Ekman R, Snochowski M, et al:  Correlation between clinical response to hormone therapy and steroid receptor content in prostatic cancer . Cancer Res 1978;;38:4345-4348.
Johns ME, MacLeod RM, Cantrell RW:  Estrogen receptors in nasopharyngeal angiofibromas . Laryngoscope 1980;;90:628-634.

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Molten A, Warpeha R, Brizio-Molteni L, et al:  Estradiol receptor-binding protein in head and neck neoplastic and normal tissue . Arch Surg 1981;;116:207-210.
Scatchard G:  The attractions of proteins for small molecules and ions . Ann NY Acad Sci 1949;;51:660-672.
Lowry OH, Rosebrough NJ, Farr AL, et al:  Protein measurement with the folinphenol reagent . J Biol Chem 1951;;193:265-275.
Jensen EV, deSombre R:  The diagnostic implications of steriod binding in malignant tissues . Adv Clin Chem 1977;;19:57-59.
McCarthy KS Jr, McCarthy KS Sr:  Steriod hormone receptors in the regulations of differentiation . Am J Pathol 1977;;86:704-744.
McGuire WL, Horwitz KB, Zava DT, et al:  Hormones in breast cancer: Update 1978 . Metabolism 1978;;27:487-501.
Parl FF, Wagner RK:  The histopathological evaluation of human breast cancer in correlation with estrogen receptor values . Cancer 1980;; 46:362-367.
Stedman KE, Moore GE, Morgan RT:  Estrogen receptor proteins in diverse human tumors . Arch Surg 1980;;115:244-248.
McCarty KS Jr, Barton TK, Fetter BF, et al:  Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma . Cancer 1980;;46:2851-2858.
Concoline G, Marocchi A, Contil C, et al:  Human renal cell carcinoma as a hormone dependent tumor . Cancer Res 1978;;38:4340.
McClendon J, Appleby D, Clandon D, et al:  Colonic neoplasms: Tissue estrogen receptors and carcinoembryonic antigens . Arch Surg 1977;;112:240-241.
Fischer RI, Neifeld JP, Lipmann ME:  Oestrogen receptors in human malignant melanoma . Lancet 1976;;2:337-338.
Gustaffson J, Ekman R, Snochowski M, et al:  Correlation between clinical response to hormone therapy and steroid receptor content in prostatic cancer . Cancer Res 1978;;38:4345-4348.
Johns ME, MacLeod RM, Cantrell RW:  Estrogen receptors in nasopharyngeal angiofibromas . Laryngoscope 1980;;90:628-634.

Correspondence

CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.